Trial Profile
The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2017
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary) ; Methylprednisolone
- Indications Sudden hearing loss
- Focus Therapeutic Use
- Acronyms YY_TNI_2011
- Sponsors Yuyu
- 07 Mar 2017 New trial record